Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer

QR Code

Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer

Background. Neoadjuvant chemotherapy (NACT) is an important stage in the treatment of patients with breast cancer. Positron emission tomography/computed tomography (PET/СT) with fluorodeoxyglucose labeled with 18F (18F-FDG) is widely used as an effective method of metabolic tumor imaging at the stag...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Chanchikova, E. A. Karlova, A. S. Savelyeva, O. A. Silkina, V. I. Chernov, R. V. Zelchan, O. D. Bragina, A. A. Medvedeva
Format:	Article
Language:	Russian
Published:	ABV-press 2021-01-01
Series:	Опухоли женской репродуктивной системы
Subjects:	breast cancer positron emission tomography neoadjuvant chemotherapy morphological response prognosis
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/762
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

POSITRON EMISION TOMOGRAPHY FOR DETECTION OF DISTANT METASTASES IN PATIENTS WITH BREAST CANCER
by: N. G. Chanchikova, et al.
Published: (2020-03-01)

POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

DIFFERENTIAL DIAGNOSIS OF BRAIN GLIOMAS BY POSITRON EMISSION TOMOGRAPHY USING VARIOUS RADIOPHARMACEUTICALS
by: N. A. Kostenikov, et al.
Published: (2016-02-01)

PROGNOSTIC VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN THE EARLY EVALUATION OF THE EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia
by: A. S. Chaban, et al.
Published: (2019-06-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
by: A. Yu. Dobrodeev, et al.
Published: (2023-01-01)

Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01)

Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01)

The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas
by: N. G. Chanchikova, et al.
Published: (2021-07-01)

A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
by: Kazuhisa Tanaka, et al.
Published: (2019-05-01)

Assessment of the Effect of Treatment with Neoadjuvant Chemotherapy on Breast Cancer Axillary Lymph Node
by: Savelina Popovska, et al.
Published: (2013-12-01)

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results
by: M. V. Sedova, et al.
Published: (2023-09-01)

Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer
by: Pantaleo Greco, et al.
Published: (1997-02-01)

Effects of the Intestinal Microbiome and Metabolites on Neoadjuvant Chemotherapy Efficacy in Breast Cancer
by: Jingyue Fu, et al.
Published: (2025-07-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01)

ROLE OF POSITRON EMISSION TOMOGRAPHY IN THE HEMODYNAMIC EVALUATION OF BRAIN TUMORS
by: A. A. Stanzhevskiy, et al.
Published: (2016-02-01)

BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-08-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
by: Apar Pataer, et al.
Published: (2018-06-01)

Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
by: Waluyo Sugito, et al.
Published: (2022-04-01)

Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis
by: M. M. Tsyganov, et al.
Published: (2020-09-01)

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

Possibilities of positron emission tomography in the diagnosis of primary and recurrent ovarian cancer: a review of literature
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01)

Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01)

Comparison of Neoadjuvant Chemotherapy With FLOT and Modified DCF Regimens in Nonmetastatic Gastric Adenocarcinoma
by: Mehdi Pourghasemian, et al.
Published: (2025-06-01)

Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
by: Tan Q, et al.
Published: (2025-05-01)

Magnetic resonance imaging in evaluation of efficiency of neoadjuvant chemotherapy of breast cancer
by: A. V. Komyahov, et al.
Published: (2015-12-01)

STAGE IB2–IIIB CERVICAL CANCER: NEOADJUVANT CHEMOTHERAPY, RADICAL SURGERY AND PATIENT SURVIVAL
by: D. L. Ovodenko, et al.
Published: (2021-06-01)